Teva Pharma New Zealand is out of stock of Arrow-Lattim (latanoprost 0.005% with timolol 0.5%) eye drops due to a delay in manufacturing, a Pharmac notice has advised.  

Pharmac said it had received advice that people can use separate latanoprost (0.005% 2.5ml) and timolol (0.5% 5ml) eye drops. This will require new prescriptions and will attract two co-payment fees for those who are not exempt from paying a co-payment, it said.  

The supplier expects resupply to pharmacy wholesalers from 25 October onwards.   

For more, see https://pharmac.govt.nz/medicine-funding-and-supply/medicine-notices/arrow-lattim-latanoprost-with-timolol-0-0050-5-2-5ml-eye-drops-supply-issue